Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Audrick Gibert
Observed name:
A. Gibert
Observed institution:
Inserm
ORCID:
0000-0002-8928-7057
Observed ORCID:
0000-0002-8928-7057
OpenAlex ID:
A5014269002
Population pharmacokinetic model of cefazolin in total hip arthroplasty
2021
·
J. Lanoiselée
, R. Chaux
, et al.
·
Scientific Reports
·
24
PDF
Factors Influencing Unfractionated Heparin Pharmacokinetics and Pharmacodynamics During a Cardiopulmonary Bypass
2024
·
Audrick Gibert
, Julien Lanoiselée
, et al.
·
Clinical Pharmacokinetics
·
4
Development of a Bayesian estimation tool to determine the optimal duration of apixaban discontinuation before a high‐bleeding risk procedure
2022
·
Audrick Gibert
, Julien Lanoiselée
, et al.
·
Fundamental and Clinical Pharmacology
·
4
Optimising protamine dosing for heparin reversal after cardiopulmonary bypass: a population pharmacokinetic–pharmacodynamic study
2026
·
Julien Lanoiselée
, Audrick Gibert
, et al.
·
British Journal of Anaesthesia
·
3
PDF
Modélisation pharmacocinétique/pharmacodynamique pour l'optimisation de la gestion des traitements anticoagulants
2024
·
Audrick Gibert
·
theses.fr (ABES)
Show more works
View as search
Works count:
5
Citation count:
35
H-index:
3
I10-index:
1
Year
Topic
Type
